Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK): Opinion on medicine for use outside EU

lamivudine / zidovudine

Opinion on medicine for use outside the European Union
Withdrawn opinion

Overview

The opinion for Lamivudine / Zidovudine ViiV for use outside the European Union has been withdrawn at the request of the opinion holder.

Opinion details

Product details
Name of medicinal product
Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK)
Agency opinion number
H/W/672
Opinion status
Withdrawn opinion
Active substance
  • lamivudine
  • zidovudine
International non-proprietary name (INN) or common name
  • lamivudine
  • zidovudine
Therapeutic area (MeSH)
HIV Infections
Anatomical therapeutic chemical (ATC) code
J05AR01
Publication details
Opinion holder

ViiV Healthcare UK Limited
980 Great West Road
Brentford
Middlesex
TW8 9GS
United Kingdom

Date of opinion
17/11/2005

Product information

17/09/2015 Lamivudine / Zidovudine ViiV (previously Lamivudine / Zidovudine GSK) H-W-672-WS-0755

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

Antivirals for systemic use

Therapeutic indication

Lamivudine/zidovudine is indicated as part of antiretroviral combination therapy for the treatment of human immunodeficiency virus (HIV) infected adults and children.

Assessment history

How useful was this page?

Add your rating
Average
1 rating